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Abstract
Non-structural protein 2 (NS2) plays an important role in hepatitis C virus (HCV) assembly, but neither the exact contribution
of this protein to the assembly process nor its complete structure are known. In this study we used a combination of
genetic, biochemical and structural methods to decipher the role of NS2 in infectious virus particle formation. A large panel
of NS2 mutations targeting the N-terminal membrane binding region was generated. They were selected based on a
membrane topology model that we established by determining the NMR structures of N-terminal NS2 transmembrane
segments. Mutants affected in virion assembly, but not RNA replication, were selected for pseudoreversion in cell culture.
Rescue mutations restoring virus assembly to various degrees emerged in E2, p7, NS3 and NS2 itself arguing for an
interaction between these proteins. To confirm this assumption we developed a fully functional JFH1 genome expressing an
N-terminally tagged NS2 demonstrating efficient pull-down of NS2 with p7, E2 and NS3 and, to a lower extent, NS5A.
Several of the mutations blocking virus assembly disrupted some of these interactions that were restored to various degrees
by those pseudoreversions that also restored assembly. Immunofluorescence analyses revealed a time-dependent NS2
colocalization with E2 at sites close to lipid droplets (LDs) together with NS3 and NS5A. Importantly, NS2 of a mutant
defective in assembly abrogates NS2 colocalization around LDs with E2 and NS3, which is restored by a pseudoreversion in
p7, whereas NS5A is recruited to LDs in an NS2-independent manner. In conclusion, our results suggest that NS2
orchestrates HCV particle formation by participation in multiple protein-protein interactions required for their recruitment
to assembly sites in close proximity of LDs.
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Introduction
Chronic infection with the hepatitis C virus (HCV) is amongst
the most frequent causes of liver cirrhosis and hepatocellular
carcinoma [1]. About 3% of the world population is persistently
infected with this virus and inspite of significant decline of new
infections, owing to the long incubation period, a profound rise in
the frequency of long-term complications such as steatosis,
cirrhosis and liver cancer is expected [2].
HCV is the predominant member of the genus Hepacivirus in
the family Flaviviridae. These viruses are enveloped and possess a
single strand RNA of positive polarity. In case of HCV the genome
has a length of ,9.6 kb and it encodes a single polyprotein that is
cleaved co- and post-translationally by cellular and viral proteases
into 10 different products [3,4]: core, envelope protein 1 (E1), E2,
p7, nonstructural protein 2 (NS2), NS3, NS4A, NS4B, NS5A and
NS5B. Core, E1 and E2 are the main viral constituents of the
HCV particle. P7 and NS2 are essential ‘co-factors’ for virus
assembly [5,6], but dispensable for RNA replication [7]. This
process is catalyzed by the concerted action of NS3 to NS5B
proteins forming –together with cellular proteins- a membrane-
associated replicase complex [8].
Studies of HCV assembly and release have become possible
with the identification of the genotype 2a isolate JFH1 that
efficiently replicates in the human hepatoma cell line Huh-7 and
supports production of infectious virus particles [9]. This culture
system has been improved by the identification of virus titer-
enhancing mutations increasing infectivity yields by up to 1,000-
fold [10–12] and the construction of JFH1 chimeras in which the
region encoding core to NS2 has been replaced by analogous
genome fragments from other HCV isolates [13,14].
With the advent of these cell culture systems, first insights into
HCV assembly and the roles of p7 and NS2 in this process could
be gained. P7 is a small hydrophobic protein composed of two
transmembrane segments (TMS) [15,16]. It is capable to form
hexa- or heptameric complexes that can act as a viroporin
[17–19]. P7 is dispensable for RNA replication [7], but crucial for
infectivity in vivo [20] likely because of its critical role in virus
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particle assembly [5,21]. Whether p7 is a component of the virion
is discussed controversially [21,22].
NS2 is a 217 amino acids (aa) long cysteine-protease composed
of a highly hydrophobic N-terminal membrane binding domain
(MBD) and a C-terminal globular and cytosolic protease
subdomain. The latter is capable to form dimers creating a
composite active site [23]. This protease is not directly required for
RNA replication, but has to be cleaved off the N-terminus of NS3
to allow formation of an active replicase [24]. Recently it was
shown that NS2 is essential for HCV assembly [5,6]. Interestingly,
protease activity is not required for particle formation, but rather
global integrity of both NS2 subdomains [25,26]. Although the
precise mode-of-action of NS2 during HCV assembly is not
known, a recent study suggests that this protein acts at a late stage
of infectious particle formation [27].
The exact membrane topology and architecture of the N-
terminal MBD of NS2 is not known. It might be composed of
three trans-membrane segments (TMS) [28], but alternative
models are possible. We have recently shown that TMS1 (aa 1–
23) adopts an overall helical fold interrupted by flexible glycine
residues at position 10 and 11 [6]. While TMS-1 is clearly
predicted as a single membrane-spanning trans-membrane helix,
this is less clear for TMS2 and TMS3 that may span the
membrane bilayer or reside on its cytosolic surface in a helix-loop-
helix configuration.
By using combinations of reverse genetic and biochemical
approaches, convincing evidence has been obtained that also
factors of the viral replicase are essential for particle formation,
most notably NS3 and NS5A [25,29–32]. The latter is a highly
phosphorylated RNA binding protein composed of an N-terminal
amphipathic alpha-helix serving as a membrane anchor and
contributing to targeting of the protein to lipid droplets (LDs)
[33,34], and three domains [35]. Domain I forms a dimer and is
essential for RNA replication [36]. Most of domain II is
dispensable for replication [30] whereas the C-terminal domain
III is essential for virus production, most likely via interaction with
the core protein [32]. This interaction appears to be regulated by
casein kinase II-mediated phosphorylation of NS5A [29].
Assembly of HCV particles is tightly linked to lipid metabolism,
LDs and the machinery required for production and secretion of
very-low-density lipoproteins (VLDL) [31,37–39]. Several models
of HCV assembly have been put forward, but the precise details
are unknown (reviewed in [40]). While these models can explain
the early steps of nucleocapsid formation, it is unclear how these
nucleocapsids acquire the membranous viral envelope and the
envelope glycoproteins and how this process is linked to VLDL
formation and secretion. NS2 may play a central role in these
reactions, but the precise mechanisms are not known [25,27].
In this study we undertook a detailed structural and functional
characterization of the N-terminal MBD of NS2. We solved the
NMR-structures of TMS2 and TMS3 and propose a model of
NS2 membrane topology. In addition, we performed a structure-
activity study of the MBD and established an interaction map of
NS2. The data reveal that NS2 serves as a key organizer
participating in multiple protein-protein interactions that are
required for the assembly of infectious HCV particles.
Results
Mapping of transmembrane domains in NS2 and
tentative model of its membrane topology
We reported recently that a transmembrane segment denoted
TMS1 was almost invariably predicted in the very N-terminal
region (aa 1–23) of NS2, irrespective of the analyzed genotypes
and subtypes [6]. TMS in the 23–102 region ([6] and references
therein) yielded inconsistent results that depended both on the
genotype examined and the method used (data not shown). By
using secondary structure predictions and the algorithm developed
by Wimley and White to calculate the propensity of an aa
sequence to interact with membranes (Figure S1, A and B) we
could deduce that the consensus segments 17–45 and 72–96
exhibit a clear propensity to partition into the membrane bilayer
and likely include transmembrane helical passages (Figure 1A and
supplementary Figure S1). In contrast, the aa segment 49–71 is
predicted not to show such properties. Based on these results, the
NS2 MBD sequence was divided into the three segments: 1–27,
27–59, and 60–99, each containing a putative transmembrane
helix (Figure 1A).
To determine the capacity of these segments to associate with
membranes, we analyzed proteins comprising full length NS2 or
putative NS2 TMS that were C-terminally fused to green
fluorescent protein (GFP) by fluorescence microscopy. The NS2-
GFP fusion protein showed a fluorescence pattern that included
the nuclear membrane, was strongest in the perinuclear region,
and extended in a reticular pattern throughout the cytoplasm
(Figure 1B). This pattern corresponds to the endoplasmic
reticulum (ER), as corroborated by the colocalization with protein
disulfide isomerase (PDI). Each of the predicted TMS of NS2
showed a very similar subcellular localization whereas GFP
expressed individually was diffusely distributed throughout the
cell including the nucleus. These observations indicate a clear
propensity of each of the three segments to associate with
membranes.
To gain insight into the structure and membranotropic
properties of NS2 segments 27–59 and 60–99, the corresponding
peptides of the Con1 strain (1b) designated NS2[27-59] and
NS2[60-99] were chemically synthesized, purified to homogeneity,
and their structures were analyzed by circular dichroism and
nuclear magnetic resonance in membrane mimetic environments
(for details see supplementary Figure S1 and materials and
methods S1). The 3D model structures obtained for both peptides
identified one a-helical segment in case of NS2[27-59] and three
well defined helical segments in case of NS2[60-99] (Figure 1C).
Based on physicochemical considerations, a transmembrane
orientation of the amphipathic a-helix in TMS2 could only be
achieved upon interaction with another complementary TMS
Author Summary
Formation of infectious virus particles (assembly) is a
complex process by which structural proteins and the viral
genome must be transferred to the same subcellular sites
to allow their direct or indirect interaction. In case of the
hepatitis C virus (HCV), this process appears to take place
in close proximity of lipid droplets (LDs) and requires in
addition to the structural proteins core, envelope glyco-
protein 1 (E1) and E2 two auxiliary factors, designated p7
and nonstructural protein 2 (NS2), contributing to virion
formation by unknown mechanisms. In this study we used
a combination of structural, genetic and biochemical
assays to study the role of NS2 in HCV assembly. By using
nuclear magnetic resonance spectroscopy of NS2 peptides
we established a membrane topology model of the amino-
terminal membrane binding domain of NS2. We found that
this protein participates in multiple interactions with E2,
p7, NS3 and NS5A that appear to recruit the viral proteins
to sites in close proximity of LDs. In this respect, NS2 is a
key organizer of the assembly of infectious HCV particles.
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neutralizing the polar and charged residues located in the
hydrophobic core of the membrane. In case of NS2[60-99], the
35 aa segment including all three helices would be too long for a
single transmembrane passage given the average length of
transmembrane helices (16 to 25 aa). As the most hydrophobic
stretch extends between aa 82–93, and considering that both edges
of this stretch include large hydrophobic residues, we assume that
segment ,77–97 forms a TMS. The first small helix (64–69),
which includes the short hydrophobic stretch VILL might be
located in the membrane interface, possibly in-plane of the
membrane.
These considerations together with the available structural data
for NS2 TMS1 [6] allow us to propose a model for the membrane
association and topology of NS2 MBD (Figure 1D). It would
contain three transmembrane, mainly helical segments (TMS1: 4–
23; TMS2: 27–49; and TMS3: 72–94), connected by a small
cytosolic loop (aa 24–26) and by a luminal segment (aa 50–71)
containing a short helix supposed to interact with the membrane
interface. Although in this model the three TMS and protease
ectodomain are represented as separated entities, given the
dimeric structure of the protease domain [23] we expect a packed
overall NS2 structure and eventually higher-order complexes of
NS2 dimers mediated by intermolecular interactions between
MBDs.
Experimental design to study the NS2 membrane
binding domain by reverse genetics
To correlate the structure of NS2 MBD with function, we
conducted an extensive mutagenesis of this domain based on the
NMR secondary structures in order to identify residues and
structural determinants that are most critical for HCV assembly
without affecting RNA replication. Mutants with a very low, but
still detectable assembly competence were then used to select for
pseudoreversions capable to rescue the assembly defect, which was
achieved by serial passage of virus in Huh7.5 cells. We anticipated
that these pseudoreversions would reside either within NS2, which
might be used to refine the structure model, or in other viral
proteins that thus would be candidates for interaction with NS2.
For the reverse genetic studies we used the JFH1 derivative
JFH1mut4-6 containing three mutations (V2153A and V2440L in
NS5A and V2941M in NS5B) elevating virus titers close to the
level of the highly efficient chimera Jc1 (,106 TCID50/ml)
without affecting RNA replication [10] (Figure 2A). We chose
JFH1mut4-6 for several reasons: first, assembly efficiency of the
parental JFH1 genome is very low (,103 TCID50/ml), which
precludes its use to select for pseudoreversions; second, the titer
enhancing mutations reside in the replicase, thus avoiding possible
effects on the structural proteins and the assembly factors p7 and
NS2; third, the Jc1 chimera has a cross-over site of two different
HCV genomes within NS2 [14], which may confound phenotypes
caused by mutations within NS2.
Intergenotypic swap of TMS domains within NS2 and
impact on infectious HCV particle production
In the first set of experiments we generated a panel of NS2
mutants in which individual a-helices of the different TMS of
JFH1mut4-6 were replaced by those of the genotype 1b isolate
Con1. These ‘helix-swap’ mutations should not affect the
secondary structure and thus preserve overall structure, folding
and topology of NS2, but disrupt genotype-specific protein-protein
interactions. Importantly, since each of the exchanged a-helices of
JFH1 and Con1 differ by several aa residues the risk to select for
revertants rather than pseudorevertants was very low.
Based on the NMR structures reported earlier [6] and in this
study, we constructed 7 helix-swap mutants (aa sequences of
affected helices are boxed in Figure 1A): JFH1-CT1.h and CT2.h
in which we exchanged the a-helix of TMS1 (aa 11–22 of NS2) or
TMS2 (aa 34–46), respectively; JFH1-CT3.h1, JFH1-CT3.h2 and
JFH1- CT3.h3 in which the individual short a-helices of TMS3
were exchanged (aa 62–69; 75–85 and 89–97, respectively). In
addition, we generated constructs JFH1-CT3.h12 and CT3.h23 in
which two short a-helices of TMS3 were exchanged at the same
time (aa 62–85 and 75–97, respectively).
As shown in Figure 2B, save for the mutant in which a-helix1 in
TMS3 was exchanged (mutant JFH1-CT3.h1), all mutants were
profoundly impaired in virus production and infectivity titers were
reduced up to 1,000 fold at 72 h after transfection of Huh7.5 cells.
This impairment correlated with the degree of sequence
conservation between the exchanged helices. Aa sequence
alignments revealed that Con1 – JFH1 sequence similarities were
Figure 1. Model of the membrane binding domain of NS2 and its orientation in the membrane. (A) Sequence comparison of the NS2
segment 1–100 from Con1 and JFH1 used to design the NS2 mutants. Amino acids are numbered with respect to NS2. The helical segments in the
membrane binding domain deduced from NMR analyses of Con1 NS2 peptides ([6] and this study) are shown at the top (h, helical). Identical, highly
similar, and similar residues at each position are symbolized by an asterisk, a colon, and a dot, respectively, according to Clustal W convention. Boxes
indicate helix segments that were exchanged with the helix-swap mutants (for nomenclature of the mutants see legend to Figure 2). Residues
exhibiting strong physico-chemical differences within these boxes are colored violet. Arrows indicate residues that were mutated in this study and
point to the substituting residues that are color-coded according to their effect on infectious particle assembly: green, no significant effect; orange
and red, medium and strong reduction of infectious virus production, respectively. Green double arrows shown in the bottom refer to the three
putative TMS as deduced from the predictions. (B) Membrane association mediated by individual NS2 TMS. U-2 OS cells were transiently transfected
with pCMVNS2-GFP or pCMVGFP (upper panel) or with pCMVNS21-27-GFP, pCMVNS227-59-GFP, pCMVNS260-99-GFP or pCMVNS21-99-GFP, as indicated
in the captions (lower panel). Twenty four to 48 h later cells were fixed and analyzed by confocal laser scanning microscopy. GFP fusion proteins were
detected by autofluorescence, ER membrane localization of NS2-GFP was confirmed by indirect immunofluorescence by using PDI as ER marker
(upper panel). (C) Ribbon diagrams of representative NMR structures of NS2[27-59] and NS2[60-99] (left and right, respectively). Residues are color-
coded according to their physicochemical properties. Hydrophobic residues are grey, aromatic residues are dark grey, Gly is light grey, Pro is black.
Polar residues are yellow and positively and negatively charged groups of basic and acidic residues are blue and red, respectively. Histidine residues
are cyan, the cystein residue is green. Some aa are labelled to provide a visual reference for residue positions in the structures. Figures were
generated from structure coordinates (PDB entry: 2KWT and 2KWZ for NS2[27-59] and NS2[60-99], respectively) by using the VMD program [67]) and
rendered with the POV-Ray software package. (D) Model of NS2 membrane topology. In the left panel TMS 1, 2 and 3 are shown in ribbon
representation and colored bronze, green and copper, respectively. The TMS are tentatively positioned in the membrane and the limits of
transmembrane helices are given (TMS1, 4–23; TMS2, 27–49; and TMS3, 72–94). The three TMS are represented as separated entities, since their
intramolecular and/or intermolecular interactions are not known. The NS2 protease domain is shown in surface representation (side view) with dimer
subunits (PDB entry 2HD0) shown in light blue and pink. For simplicity, the MBD for only one protease subunit is shown. The phospholipid bilayer is
tentatively and schematically represented. The ribbon model of NS2 MBD in the right panel shows the location of mutated residues analyzed in this
study. Side chain atoms of mutated aa are shown as spheres corresponding to van der Waals radius and color-coded as described in panel A to
indicate the assembly phenotype. Backbones of residues with low similarity in helix-swap mutants are colored violet.
doi:10.1371/journal.ppat.1001233.g001
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in the range of 58–81%, but in case of helix1 of TMS3 similarity
was only 37%. Since this helix swap mutant was unaffected in
assembly, this region most likely is required for interactions with
the membrane and thus genotype independent.
Analysis of intra- and extracellular infectivity revealed that in all
cases reduced titers were due to impaired assembly rather than virus
release (Figure 2C). With the exception of mutant CT3.h23
producing lower amounts of NS2 assembly defects could not be
ascribed to gross alterations of NS2 abundance (Figure 2D). The
protein of higher molecular weight detected with mutant JFH1-
CT2.h corresponded to uncleaved p7-NS2 arguing for a processing
defect of this mutant, which was not the case for all the other
mutants. In addition, a distinct product of smaller size (about
16 kDa) was detected on longer exposure (not shown) and this
protein most likely corresponds to an N-terminal cleavage product
of NS2 designated tNS2 [6] (see below). In summary, these results
show that the integrity of the N-terminal MBD of NS2 is important
for HCV assembly and that all 3 TMS are required.
Figure 2. Exchange of helices within the NS2 membrane binding domain and impact on infectious HCV particle production. (A) A
schematic diagram of the cell culture adapted JFH1 genome construct (JFH1mut4-6; [10]) used for functional characterization of the NS2 membrane
binding domain (MBD) is shown in the top. The titer enhancing mutations are indicated with asterisks. The membrane topology model of the N-
terminal MBD is schematically shown below. Helices in individual TMS are represented by cylinders and numbered. Note that TMS3 contains 3
individual helices (h1–h3). C refers to Con1 that was used to replace the corresponding JFH1 fragment in NS2. For instance, CT1.h refers to the
replacement of the helix of JFH1 TMS1 by the one of Con1 etc. (B) Huh7.5 cells were transfected with constructs specified in the bottom and kinetics
of release of infectious particles into culture supernatants were quantified at time points given in the top by TCID50 assay. (C) Intracellular and
extracellular infectivities were determined 48 h post transfection by using TCID50 assay. In panels (B) and (C) representative results of three
independent experiments with standard deviations are shown. Background of the assays was determined by using the JFH1-DE1E2 mutant in which
the region encoding the envelope glycoproteins was deleted and that does not release infectious particles (black line and arrow head). (D) Western
blot analysis of HCV proteins expressed in Huh7.5 cells after transfection with constructs specified in the bottom. Cell lysates were prepared 48 h post
transfection and proteins were detected by using antibodies with specificities given to the right side of each panel. Beta-actin detected on the same
blot was used as internal loading control.
doi:10.1371/journal.ppat.1001233.g002
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Identification of single amino acid residues in the NS2
membrane binding domain that are essential for HCV
assembly
To further narrow down the regions within individual TMS of
NS2 that are most crucial for assembly, we generated a panel of
single aa substitutions that were designed on the basis of the degree
of conservation across the different genotypes, aa size, charge,
polarity and hydrophobicity (Figure 1A). Large and hydrophobic
aa were replaced by smaller and less hydrophobic ones (Y26P,
Y39A, W51A, F77A or LL83-84AA); small aa probably serving as
flexible linkers between individual a-helices were replaced by
larger aa assumed to reduce flexibility of the N-terminal MBD
(G10A/S/T/P, P53I, P73I and G88L); charged aa potentially
involved in electrostatic interactions were replaced by aa with
opposite charge thus possibly introducing repulsive forces (K27E,
E45R, R58E, R61E and K81E); finally, the polar threonine
residue at position 80 was replaced by the larger and hydrophobic
aa leucine. All mutants were tested for protein expression, kinetic
of infectivity release as well as amounts of intra- and extracellular
infectivity. The results shown in Figure 3A and B demonstrate that
both infectivity release and intracellular infectivity levels were
reduced with all mutants, albeit to very different degrees. In
agreement with our earlier results demonstrating the important
role of the glycine residue at position 10 for virion assembly [6], we
found that mutants G10P and G10T did not support virus
production and even less drastic alanine or serine substitutions
reduced infectivity titers up to 300-fold. Substitutions residing in
loop1 that connects a-helix 1 and 2 strongly reduced or completely
abolished production of infectious HCV particles (Y26P and
K27E, respectively). In contrast, aa substitutions in loop2 (W51A,
P53I, R58E and R61E) slowed down the kinetic of infectivity
release, which was best detected at 24 h post transfection, whereas
intra- and extracellular infectivity titers were reduced only
moderately at later time points as compared to the parental
construct JFH1mut4-6 (wt).
Alanine substitutions of aromatic aa residues in TMS2 (Y39) or
TMS3 (F77) reduced infectivity titers up to 1,000-fold whereas
mutations introducing electrostatic repulsion in TMS2 or TMS3
(E45R and K81E, respectively) blocked virus production almost
completely. Substitutions targeting the flexible region between
helix one and two or helix two and three in TMS3 (P73I and
G88L, respectively) strongly reduced infectivity titers (1,000-fold at
72 h p.e.). Surprisingly substitutions affecting the highly conserved
polar aa residue at position 80 (T80L) or the two leucine residues
at positions 83 and 84 (LL83-84AA) did not give rise to a
detectable phenotype. Interestingly, as shown in Figure 1D,
residues 80, 83 and 84 are located on one helix side, suggesting
that it is not important for protein – protein interactions. In
contrast, residues 77 and 81 are located on the opposite side,
arguing that this helix side might be involved in interactions.
Western blot analysis of NS2 proteins expressed in cells after
transfection with each of the mutants or the parental construct
revealed no gross difference in the abundance of this protein and
the other HCV proteins arguing for similar replication levels and
protein stabilities (Figure 3C). Nevertheless, some variations in
abundance of individual HCV proteins were detected such as
lower amounts of NS2 in case of K81E and reduced amounts of
core protein in case of LL83AA. However, these rather subtle
differences are very unlikely to account for the often drastic
impairment of HCV assembly. In agreement with an earlier
report, ‘truncated NS2’ [6] was detected to variable levels, but its
abundance did not correlate with assembly phenotypes.
Given the important role of tryptophan in protein-protein
interaction within a membrane [41] and their preferred location at
the membrane interface [42,43], we also analyzed a panel of
mutations affecting the two fully conserved W35 and W36
residues. A striking correlation was found between reduction of
aromaticity as well as size of residues at these sites and reduction of
virus production (data not shown) arguing that the aromatic side
chains of W35 and W36 are involved in essential interactions such
as membrane tethering of TMS2 via aromatic ring stacking.
Selection for pseudoreversions rescuing assembly
defects caused by mutations within the NS2 membrane
binding domain
Having generated a panel of NS2 mutants with a selective
assembly defect, and –in some cases- an additional virus release
defect (e.g. Y26A; Figure 3B) we wanted to establish a genetic
interaction map of NS2. For this purpose we used a cell culture
adaptation strategy, which was possible, because the parental
construct JFH1mut4-6 that was used for mutagenesis already
supports high level virus production and therefore, selection for
pseudoreversion would not give rise to undesired mutations
enhancing assembly in general [10]. Culture supernatants
collected from cells 72 h after transfection with a given NS2
mutant were concentrated and used to infect naive Huh7.5 cells
that were passaged 6 times. After 4 additional passages of culture
supernatants, they were used to inoculate naı¨ve Huh7.5 cells and
virus titers produced therefrom were determined by TCID50 assay.
In case of mutants with elevated virus titers, cell lysates were used
to prepare total RNA, HCV genomes were amplified by RT-PCR
and amplicons spanning most of the 59 NTR up to the middle of
NS3 were either directly sequenced or cloned prior to sequence
analysis. In the latter case at least two independent clones were
analyzed and only mutations conserved between the two cDNA
clones were considered in order to discriminate against mutations
that might have been introduced by PCR. Pseudoreversions
outside the analyzed region, including NS5A, were not considered
because we used the JFH1mut4-6 genome that already contained
titer-enhancing mutations in NS5A to allow adaptation. Mutations
identified by this approach were inserted into the corresponding
parental NS2 mutant and replication as well as assembly
properties were analyzed by Western blot and TCID50 assays. A
summary of all pseudoreversions identified in this way along with
their degree of titer enhancement is given in Table 1.
Several assembly deficient mutants (G10T, G10P, K81D, G88L
and JFH1-CT3.h23) could not be adapted, because the virus was
rapidly lost during cell passages suggesting that the genetic barrier
was too high and assembly impairment too strong. Nevertheless,
for most mutants we could select for pseudoreversions with the
exception of G10A and K81E where reversion to wild type
occured, which was achieved by just one nucleotide substitution.
Since we had inserted in addition a silent nucleotide exchange in
the subsequent codon that was retained in the selected virus, we
could rule out a contamination with wild type virus. All of the
other adapted mutants contained pseudoreversions. They resided
primarily within NS2 and two ‘classes’ of pseudoreversions could
be discriminated: first, those residing at the same position as the
primary mutation, but with a different substituting aa residue;
second, pseudoreversions at a different site than the primary
mutation. Pseudoreversions belonging to the first class (R45G and
I73S) enhanced virus production 88,000- and 3,100-fold and thus
back to the level of the parental genome JFH1mut4-6 (Figure 4A
and Table 1). Pseudoreversions belonging to the second class
(double mutants G10S-T23N, W36F-Q32R and Y39A-G25R)
increased infectivity titers ,220-, 450- and 10-fold, respectively,
with G10S-T23N also reaching wild type levels (Figure 4A and
Table 1). For this reason the T23N substitution was also combined
Role of NS2 in HCV Assembly
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with mutants G10T and G10P, but titer increase was very
moderate (Figure 4A).
In addition to pseudoreversions in NS2, one particular mutation
was identified in NS3 (Q221L) that rescued infectivity titers of the
W35F and the W36L mutants by 1,400- and 38,000-fold
(Figure 4B). This NS3 mutation has previously been described as
a general titer enhancing substitution [25,27]. For this reason we
inserted the Q221L mutation into mutants W35A, W35L and
W36A that are completely defective in assembly and that could
not be adapted with our approach. As shown in Figure 4B,
infectivity titers were enhanced in all cases corroborating the more
general assembly enhancing phenotype exerted by this particular
NS3 mutation. Moreover, the same mutation was also capable to
rescue virus production of several NS2 mutants even in trans
(supplementary Figure S2). Although in this case rescue efficiency
was lower as compared to direct insertion of the mutation into the
Figure 3. Mutation analysis of the NS2 membrane binding domain identifies amino acid residues that are crucial for efficient virus
production. (A) Huh7.5 cells were transfected with JFH1mut4-6 or derivatives thereof containing single point mutations specified in the bottom.
Amounts of infectious particles released into the supernatants of cells 24, 48 and 72 h after transfection were determined by TCID50 assay. (B)
Comparison of intra- and extracellular infectivities obtained with Huh7.5 cells 48 h after transfection. Representative results of three independent
experiments with standard deviation are shown in panels (A) and (B). Background of the assays was determined by using JFH1-DE1E2 (black line and
arrow head). (C) Western blot analysis of viral proteins (core, NS2, NS3 and NS5A) in Huh 7.5 cells 48 h p.t. with constructs specified below the panels.
As negative control we used an NS2 mutant unable to replicate because of a mutation blocking the active site of the protease (NS2-H952A; [6]). Beta
actin detected on the same blots was used as internal loading control. Wt, wild type; tNS2, truncated NS2.
doi:10.1371/journal.ppat.1001233.g003
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Table 1. Impact of NS2 mutations and pseudoreversions within and outside of NS2 on production of infectious virus.
construct/mutant pseudo-reversion affected protein Viral titre * fold titer increase % of wt titer
wt 7.9 105+/25.6 104 n.a. 100
CT1.h 8.0 103+/21.6 103 n.a. 1.0
E3D p7 3.8 105+/23.9 104 47 48.0
F14L NS2 1.5 105+/27.8 104 19 19.0
E3D + F14L p7-NS2 6.9 105+/21.5 105 85 85.0
I17M NS3 2.4 103+/21.0 103 0.3 0.30
CT2.h 4.3 102+/21.6 102 n.a. 0.05
N15D p7 2.4 103+/22.5 102 5 0.27
G25R NS2 1.2 105+/25.8 104 265 14.4
N15D + G25R p7-NS2 1.2 105+/22.3 104 270 14.7
CT3.h2 2.4 103+/21.0 103 n.a. 0.30
E151D + I181S E1 2.9 103+/27.1 102 1.2 0.36
K172R NS2 4.0 104+/23.8 103 16 4.9
CT3.h3 1.4 103+/27.9 102 n.a. 0.18
T21A NS2 2.5 104+/21.0 103 17 3.0
Single AA substitution in TMS1
G10A 1.3 103+/21.3 102 n.a. 0.16
A10G NS2 n.a. n.a. n.a.
G10S 5.8 103+/22.9 103 n.a. 0.73
T23N NS2 1.3 106+/27.5 105 227 166
G10T 2.4 100+/21.0 100 n.a. ,0.01
T23N ** NS2 1.9 102+/29.5 101 100 0.03
G10P n.d. n.a. n.a.
T23N ** NS2 1.4 102+/28.3 101 n.a. 0.02
Single AA substitution in TMS2
W35A n.d. n.a. n.a.
Q221L ** NS3 3.4 102+/21.0 102 n.a. 0.04
W35L n.d. n.a. n.a.
Q221L ** NS3 1.9 103+/27.6 102 n.a. 0.24
W35F 8.7 101+/21.4 101 n.a. 0.01
Q221L NS3 1.2 105+/26.6 104 1,400 14
W36A n.d. n.a. n.a.
Q221L ** NS3 5.8 104+/21.3 104 n.a. 7.3
W36L 3.2 100+/26.0 10-1 n.a. ,0.01
Q221L NS3 1.3 105+/26.7 104 38,200 16.5
W36F 2.7 102+/27.4 101 n.a. 0.03
Q32R NS2 1.2 105+/26.6 104 450 15.3
Y39A 1.0 104+/27.5 103 n.a. 1.3
G25R NS2 1.2 105+/21.2 104 11 13.9
E45R 3.2 100+/24.8 10-1 n.a. ,0.01
R45G NS2 2.9 105+/23.0 104 87,900 36.7
Single AA substitution in TMS3.2
P73I 1.4 102+/26.3 101 n.a. 0.02
I73S NS2 4.3 105+/21.9 105 3,100 55.1
F77A 4.1 102+/22.4 102 n.a. 0,05
Y215S E2 n.d. n.a. n.a.
V341A E2 4.3 104+/24.0 102 100 5.4
K81E 3.9 101+/22.3 101 n.a. ,0.01
E81K NS2 n.a. n.a. n.a.
K81D 3.5 101+/21.5 101 n.a. ,0,01
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NS2 mutant genome, this observation suggests that a genetic
separation of the replication and assembly function of NS3 is
possible.
In case of the F77A mutation residing in TMS3.2 of NS2 two
mutations located in E2 could be selected: Y215S located in the
ectodomain and V341A in the N-terminus of the TMS of E2
(Table 1). When we tested these substitions in the context of the
parental NS2 mutant we found that Y215S completely abrogated
infectious virus production concomitant with a strong reduction in
intracellular NS2 amounts (Figure 4A). However, the V341A
substitution enhanced virus titer ,100-fold arguing for a (direct or
indirect) interaction between these two proteins for efficient
particle production.
A more complex pattern of mutations was found upon selection
for pseudoreversions in case of helix-swap mutants JFH1-CT1.h,
JFH1-CT2.h, JFH1-CT3.h2 and JFH1-CT3.h3 (Table 1 and
Figure 4C). For CT1.h, we found E3D residing in the N-terminal
helix of p7 [16], F14L in TMS1 of NS2 and I17M in the
membrane-binding amphipathic helix a0 of the NS3 protease
domain. When inserted into the parental virus, strongest rescue of
assembly was found with the p7 mutation and infectivity titers
were further increased 10-fold at 24 h or 2-fold at 72 h p.t. when
combined with the NS2 pseudoreversion (CT1.h - p7NS2). In
contrast, the NS3 mutation had a slightly negative effect (CT1.h-
NS3-I17M). For the JFH1-CT2.h mutant we detected two
pseudoreversions residing in the turn connecting the N-terminal
helix and the TM1 helix of p7 (N15D) [16] and the loop
connecting TMS1 and TMS2 of NS2 (G25R). In this case, the
mutation in NS2 rescued HCV assembly strongest (,265-fold)
whereas the p7 mutation had a very moderate effect and in
combination with the NS2 mutation did not enhance virus titers
further. In case of pseudoreversions detected with helix-swap
mutants JFH1-CT3.h2 and JFH1-CT3.h3, the only titer enhanc-
ing mutations were found in NS2 (K172R, T21A) with T21A
arguing for an interaction between TMS1 and TMS3 of NS2. The
double mutation identified in E1 of JFH1-CT3.h2 construct
(E151D/I181S) had no effect.
For all tested single aa mutants and helix-swap mutants and
their corresponding pseudorevertants, the enhancement of infec-
tivity titers in cell culture supernatants correlated with increased
amounts of intracellular infectivity showing that the pseudorever-
sions rescued primarily assembly rather than virus release
(supplementary Figure S3). Moreover, with the exception of the
F77A-E2-Y215S double mutant, amounts of NS2 as well as NS5A,
NS3 and core protein were not grossly altered (Figure 4 and
supplementary Figure S4, respectively) suggesting that overall
protein stabilities were not profoundly affected by the mutations.
We note however that for mutant F77A already producing
somewhat lower amounts of NS2 as compared to the wildtype,
NS2 abundance was reduced much more by the Y215S
substitution in E2. Moreover, in case of helix-swap mutant
CT2.h and the corresponding pseudorevertants cleavage between
p7 and NS2 was impaired (Figure 4C). Interestingly, even in case
of rescue mutant CT2.h-NS2, the substitution in NS2 enhancing
virus production about 250-fold does not affect the amounts of this
uncleaved precursor arguing that assembly competence of this
mutant is restored in a manner that still allows delayed p7-NS2
cleavage, thus compensating e.g. an impaired p7-NS2 interaction
(see below).
Construction and characterization of fully functional
JFH1-derived genomes encoding an N-terminally tagged
NS2 protein
Although in most cases, selection for pseudoreversion resulted in
compensatory mutations within NS2 itself, we also identified
pseudoreversions in E2, p7 and NS3. In case of helix-swap mutant
CT1.h, the E3D substitution in p7 restored almost wild type
infectivity titers (Table 1). Likewise, the assembly defect of mutant
W35F in NS2 was compensated by Q221L in NS3 and NS2
mutant F77A was compensated by the V341A substitution in E2.
These results suggested that NS2 might interact (directly or
indirectly) with each of these proteins. To support this assumption
by pull-down assays, we first generated a fully functional JFH1-
derivative with a tagged NS2 protein suitable for efficient
immunoprecipitation and allowing capture of NS2 independent
from any mutation that might affect recognition with the NS2-
specific antibody. To this end we constructed a series of mutants in
which NS2 was fused N- or C-terminally with several tags such as
the FLAG-, hexa-histidine (His)- or hemagglutinin (HA)-tag. All
genomes with C-terminal fusions no longer supported HCV
particle production (data not shown). Moreover, when we tried to
select for titer enhancing pseudorevertants of assembly deficient
NS2-tagged mutants, in all cases the tag was partially or
completely deleted (not shown). In contrast, viable mutants were
obtained with N-terminally tagged NS2 versions in which the first
5 codons of NS2 were duplicated upstream of the heterologous
sequence that was composed of a single copy of the tag and a
linker sequence encoding for Gly-Ser-Gly preceeding NS2. In
addition, variants were generated with a second insertion of the
tag sequence to increase efficiency of immunoprecipitation
(Figure 5A). Analysis of the kinetics of virus production revealed
that both the single Flag-tagged (F-NS2) and the HA-Flag-double
tagged variant (HAF-NS2) produced amounts of intra- and
extracellular virions that were comparable to the parental genome
JFH1mut4-6 (data not shown and Figure 5B). In contrast, the
variants with the tandem Flag-tag (FF-NS2) or the His-Flag-tag
combination (HisF-NS2) produced lower amounts of extra- and
intracellular infectious particles arguing for an assembly defect.
Western blot analysis revealed comparable replication of all
constructs and no defect of polyprotein processing was detected
(Figure 5C). The sizes of the various NS2 proteins and their
immunoreactivities confirmed that the tag(s) remained fused to
mature (fully processed) NS2.
construct/mutant pseudo-reversion affected protein Viral titre * fold titer increase % of wt titer
G88L 1.4 102+/24.1 101 n.a. 0,02
*72 h post transfection.
**artificial insertion of adaptive mutation; not detected during selection for pseudoreversion.
n.d.: no detectable infectivity (detection limit 2x100 TCID50/ml).
n.a.: not applicable.
doi:10.1371/journal.ppat.1001233.t001
Table 1. Cont.
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Interaction of NS2 with E2, p7, NS3 and NS5A as
determined by co-immunoprecipitation
Taking advantage of these assembly-competent tagged NS2
constructs, we selected JFH1mut4-6HAF-NS2 to determine NS2
interactants. Huh7.5 cells were transfected with this construct and
NS2-containing immunocomplexes captured from lysates that
were prepared 72 h p.t. were analyzed by Western-blot for
coprecipitation of core, E2, p7, NS3 and NS5A. Specificity of
immunoprecipitation and Western blot analysis was determined
by using the parental JFHmut4-6 construct that lacked the N-
Figure 4. Functional analysis of pseudoreversions within and outside of NS2 for their capability to restore virus particle
production. JFH1mut4-6 mutants carrying either single aa subtitutions (panel A and B) or helix swaps (C) causing a profound reduction of virion
production were used for insertion of pseudoreversions that are specified in Table 1. Parental NS2 mutants and corresponding pseudorevertants
were transfected into Huh7.5 cells and kinetic of virus production was determined by TCID50 assay at time points specified in the top. A
representative result of two independent experiments with standard deviations is shown in each panel. Background of the assays was determined by
using JFH1-DE1E2 (black line and arrow head). Shown below each panel are the NS2 expression levels of mutants and the corresponding
pseudorevertants as determined by Western blot using lysates of Huh7.5 cells prepared 48 h after transfection. A more comprehensive analysis of
additional viral proteins is shown in Supplementary Figure S4.
doi:10.1371/journal.ppat.1001233.g004
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Figure 5. Construction and functional characterization of JFH1 genomes encoding an N-terminally tagged NS2 protein. (A)
Schematic representation of the JFH1mut4-6 constructs in which the N-terminus of NS2 was fused to either the Flag-tag (F) or two copies of this tag
(FF) or a hexahistidin-Flag fusion tag (HisF) or a HA-Flag fusion tag (HAF). The cleavage site between p7 and NS2 is indicated with a dotted arrow and
the scissor; aa sequences of the duplicated N-terminal 5 aa residues and the Gly-Ser linkers are displayed. (B) Kinetic of virus production attained with
JFH1mut4-6 derivatives depicted in panel (A) was determined by transient transfection of Huh7.5 cells in parallel with the parental genome (wt). A
representative result of three independent experiments with standard deviations is shown. Background of the assays was determined by using JFH1-
DE1E2 (black line and arrow head). (C) Expression of HCV proteins was determined by Western blot analysis 48 h after transfection using antibodies
specified in the right. (D) Interaction of NS2 with structural and nonstructural proteins. JFH1mut4-6 without a tagged NS2 (wt) or a derivative thereof
with the HA- and Flag-tag fused to the N-terminus of NS2 (HAF-NS2) were transfected into Huh7.5 cells. Seventytwo hours later cells were harvested
and lysates were used for immunoprecipitation with an HA-specific antibody. After extensive washing, immunocomplexes were analyzed by
electrophoresis into a Tris-Tricine gel and subsequent Western blot using antibodies given in the right of each panel (NS2 IP). Ten percent of the input
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terminal NS2-tag. The results in Figure 5D show that the tagged
NS2 protein co-precipitated with E2, p7, NS3 and NS5A, but not
with core. In contrast, no signal was found in case of the non-
tagged genome inspite of comparable amounts of viral proteins in
cell lysates, demonstrating specificity of these co-precipitations.
To analyze whether the pseudoreversions in E2, p7 and NS3
affect the NS2 interaction pattern, we chose those NS2 mutants for
which infectivity titers were enhanced by a pseudoreversion
outside of NS2: CT1.h and CT1.h-p7-E3D; W35F and W35F-
NS3-Q221L; F77A and F77A-E2-V341A. Lysates of all samples
harvested 72 h after electroporation together with positive and
negative controls were subjected to HA-specific pull-down and
immunocomplexes were analyzed by Western blot (Figure 6A).
Pull-down efficiencies were quantified by densitometry scanning
and normalized to protein amounts detected in the corresponding
cell lysate (Figure 6B); based on this quantification fold
enhancement of coimmunoprecipitation achieved by the pseudor-
eversion was determined (Figure 6C).
For all mutants, NS2 interaction with the other viral proteins
was reduced, but to very different extents. Most pronounced was
the impairment of NS2 interaction with E2, p7 and NS3, whereas
interaction with NS5A was less affected. Importantly, the E3D
pseudoreversion in p7 introduced into CT1.h enhanced interac-
tion with E2 and NS3 back to wild type levels correlating well with
the rescue of assembly competence of this helix-swap mutant.
Unfortunately this pseudoreversion disrupted the epitope recog-
nized by the p7-specific antibody and therefore, the degree of
coprecipitation of this p7 with NS2 could not be determined.
Interaction of NS2 with NS5A was elevated even above the wild
type level (Figure 6B, C). As expected, the Q221L pseudoreversion
in NS3 introduced into the W35F NS2 mutant increased NS2 –
NS3 interaction, but surprisingly had little or no effect on NS2
interaction with E2 or p7, respectively, and even a negative effect
on interaction with NS5A (Figure 6B, C). The pseudoreversion in
the TMS of E2 (V341A) introduced into the F77A mutant
moderately enhanced interaction of NS2 with E2 and NS3, but no
significant enhancement of interaction with p7 and NS5A was
detected. Interestingly, NS2 containing this F77A substitution
coprecipitated with both phospho-variants of NS5A to the same
extent, whereas all other NS2 proteins tested preferentially
interacted with the basal phosphorylated form p56 (Figure 6A).
This phenotype of the F77A mutant was not altered by the
adaptive mutation residing in E2.
Subcellular localization studies of NS2
To support and extend the interaction patterns described above
with an alternative assay we performed colocalization studies of
NS2 with structural and other nonstructural proteins. In the initial
set of experiments, we determined the subcellular localization of
NS2 (Figure 7A) and observed a profound change from a reticular
ER staining pattern 36 h post transfection (NS2 colocalization
with the ER marker PDI is not shown) to a strong punctate NS2
stain accumulating in close proximity of LDs 72 h post
transfection. By counting ,200 cells we defined two phenotypes,
based on the number of LDs with NS2 accumulation: phenotype 1
with less than 10 NS2-positive LD structures per cell and
phenotype 2 with more than 10. A time-dependent increase of
phenotype 2 was also observed although the overall percentage
was lower, which was probably due to lower replication as
compared to RNA transfection (supplementary Figure S5).
The functional relevance of these two phenotypes is supported by
the analysis of the NS2 mutants and their respective pseudorever-
tants (Figure 7B). We found that NS2 decorated LDs were much less
frequent in an assembly deficient mutant and even 72 h after
transfection the majority of NS2 was localized at the ER.
Importantly, upon insertion of the corresponding pseudoreversion
a shift back to phenotype 2 representing higher abundance of NS2
‘positive’ LDs 72 h p.t. was detected (Figure 7B).
To determine whether other viral proteins might be recruited to
LDs in an NS2-dependent manner we performed colocalization
studies. As shown in Figure 8A, at each analyzed time point we
found a striking colocalization of NS2 and E2 in case of the wild
type, consistent with the coimmunoprecipitation results. In
addition, we detected a strong accumulation of both proteins
around LDs 72 h p.t. (Figure 8A). A similar pattern, but less
colocalization as determined by Pearson’s correlation coefficient,
was found for NS2 with NS3 (Figure 8B). Interestingly, a lower
degree of colocalization of NS2 and NS5A predominated 36 h p.t.
and NS5A localized in close proximity of LDs independent of
NS2. Accumulation of NS2 around LDs at the later time point
coincided with increased NS2-NS5A colocalization at these sites.
No significant colocalization was detected between NS2 and core
protein at LDs. However, a small amount of core colocalized with
NS2 in a reticular, presumably ER-derived compartment
(supplementary Figure S6). Attempts to detect p7 by immunoflu-
orescence were not successful with the available antibodies and
insertion of tags into p7 very much impaired assembly (not shown).
Therefore, p7 – NS2 colocalization could not be studied.
Given the most pronounced loss of NS2 accumulation around
LDs (i.e. low frequency of phenotype 1) with mutant CT1.h we
determined for this construct and the corresponding pseudor-
evertant NS2 colocalization with E2, NS3 and NS5A as well as
HCV protein accumulation at LDs. For the parental NS2 mutant
we found that E2 no longer localized to LDs and localization of
NS3 to these sites was strongly impaired (Figure 9A). However,
recruitment of these viral proteins to LDs and strong colocalization
at LDs was restored by the pseudoreversion in p7 (E3D; Figure 9A,
lower panel). In contrast, NS5A was recruited to LDs independent
from NS2 and NS2 – NS5A colocalization was also restored by
this pseudoreversion.
When analyzing a larger panel of NS2 mutants and their
corresponding pseudorevertants for colocalization of these HCV
proteins in a quantitative manner (Figure 9B) we found for CT1.h
a slight reduction of NS2 colocalization with E2, NS3 and NS5A
that was partially restored by the pseudoreversion residing in p7
(CT1.h-p7). In case of NS2 mutants W35F and F77A only NS2
colocalization with NS5A was impaired, but restored by the
corresponding pseudoreversion in NS3 or E2 (W35F-NS3-Q221L
or F77A-E2-V341A, respectively). In contrast, colocalization of
NS2 with E2 or NS3 was unaffected by these NS2 mutations
(Figure 9B). This result could be explained by the fact that the
mutations in NS2 might impair accumulation around LDs and
thus would lead to accumulation of NS2 at ER membranes where
also the majority of E2 and NS3 reside. Therefore, colocalization
of these NS2 proteins with E2 and NS3 (at the ER membrane)
might be strong. In contrast, NS5A is recruited to LDs
independent of NS2 and therefore, NS2 mutations that no longer
are recruited to LDs might have lower colocalization rate that
would be restored by the pseudoreversion that rescues ‘LD
targeting’ of NS2.
used for immuno-capture was analyzed in parallel (left panels). Mock-transfected cells served as negative control of Western blot and the wt genome
lacking the HA-tag was used as specificity control for immunoprecipitation.
doi:10.1371/journal.ppat.1001233.g005
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Figure 6. NS2 mutations and pseudoreversions and their impact on NS2 interaction with other viral proteins. JFHmut4-6 (wild type
without tag; wt), JFHmut4-6HAF-NS2 with the HA-Flag double tag or helix swap mutants and double mutants derived from this construct were
transfected into Huh7.5 cells and harvested 72 h later. (A) Cell lysates were used for immunoprecipitation (IP) with an HA-specific antibody and
immunocomplexes were analyzed by Western blot (WB) as specified to the left and right of each panel. For comparison, 10% of the lysate used for
the IP was analyzed in parallel. The wt genome lacking the HA-tag was used as specificity control for immunoprecipitation. Note that in case of the p7
mutant the pseudoreversion (E3D) resides in the epitope recognized by the p7-specific antibody and thus this p7 protein is not detected (labeled
with an arrow). (B) Western blot signals of proteins in immunocomplexes from two independent experiments were quantified by densitometry
scanning and normalized to the amounts of the respective viral protein present in the cell lysate. Values obtained with the wild type genome were
set to 100%. (C) Relative enhancement of co-immunoprecipitation of NS2 with HCV proteins specified in the top by pseudoreversions. Values
obtained with the corresponding NS2 mutant in the absence of the pseudoreversion were set to 1 (highlighted with the grey line and the black arrow
head) and used for normalization of the values measured with the pseudorevertants.
doi:10.1371/journal.ppat.1001233.g006
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Figure 7. Time-dependent change of NS2 subcellular localization. Huh7-Lunet cells were transfected with JFH1mut4-6 HAF-NS2 and 36, 48
and 72 h later, NS2 and LDs were detected by using an HA-specific antibody (red) or BODIPY staining (blue), respectively. (A) Representative images
of cells 36 and 72 h p.t. (left and right half, respectively). An overview is shown in the top, a magnification of a single cell from a different view field
below. Boxed areas are enlarged in the smaller panels to the left and right, respectively. Enlargements show 3D reconstructed images created with
the Volocity 5.3 software. In case of the 72 h value 3 representative structures are displayed. The staining pattern shown for the 36 h time point and
in panel 2 for the 72 h time point corresponds to phenotype 1. (B) Huh7-Lunet cells were transfected with the wild type (left panel) or given NS2
mutants (right panel) and analyzed as described above. Shown are the ratios of phenotype 1 and 2. In case of the wild type values determined at
different time points after transfection are shown, in case of the mutants only the values measured 72 h p.t. For each construct, 180 cells were
analyzed.
doi:10.1371/journal.ppat.1001233.g007
Role of NS2 in HCV Assembly
PLoS Pathogens | www.plospathogens.org 14 December 2010 | Volume 6 | Issue 12 | e1001233
Discussion
The important role of NS2 for HCV assembly has been shown
by several earlier reports [5,6,25–27]. However, the way this
protein contributes to virion formation remains enigmatic. We
addressed this question by using several complementary approach-
es including the structural analysis of the MBD, reverse and
forward genetic analyses and a combination of coimmunopreci-
pitation and subcellular localization studies. Our results provide
evidence that NS2 recruits the envelope glycoproteins (presumably
in conjunction with p7) and probably also NS3 to LDs and serves
as a key organizer of HCV assembly by participating in multiple
protein - protein interactions required for virion formation. The
implications of these results are discussed in the following.
Topology model of NS2 MBD
By using NMR of synthetic peptides we solved the secondary
structures of TMS2 and 3 and propose a membrane topology
model of the overall N-terminal MBD (Figure 1D). This model
supports and very much extends an earlier report [28] and
proposes 3 transmembrane a-helices, connected by flexible loop
regions. While TMS1 and 2 consist of one a-helix, TMS3 is
composed of three. Each of TMS1 - 3 is capable to mediate
membrane association on its own. To determine whether
individual helices within TMS3 are sufficient for membrane
targeting we analyzed subcellular localization patterns of NS2-
GFP fusion proteins comprising NS2 aa residues 60–88 or 74–99.
However, these proteins displayed a predominantly diffuse
fluorescence signal, arguing that all 3 helices of TMS3 are
required for membrane targeting (J.G. and D.M., unpublished).
The model of three TMS is consistent with homo-intramolec-
ular TMS interactions revealed by the pseudoreversions indicating
that TMS1 interacts with TMS2 and TMS3. The model is also
consistent with hetero-intermolecular interactions by which TMS1
and TMS2 could interact with p7 whereas TMS3 could interact
with the TMS of E1 and E2 (Figure 10). Moreover, the fact that
point mutations in the long and variable connecting loop between
TMS2 and TMS3 had no effect on virus production is in keeping
with its ER luminal location. Conversely, the sensitivity to
mutation of the small loop between TMS1 and TMS2 is consistent
Figure 8. Colocalization of NS2 with structural and nonstructural proteins and recruitment to LDs. (A) Huh7-Lunet cells were transfected
with JFHmut4-6-HAFNS2 (wild type, wt) and 36 h or 72 h later NS2 was detected with an HA-specific antibody (red). E2, NS3 or NS5A were detected
with mono-specific antisera and LDs were labeled with BODIPY (blue). Pictures were deconvolved by using the Huygens Essential 3.5 software and a
theoretical point spread function. The small inserts in the bottom of each panel represent 3D reconstructed enlargements of each corresponding
image created with the Volocity 5.3 software. (B) The degree of colocalization was quantified by determining Pearson’s correlation coefficients. For
each sample 50 cells were quantified by using the ImageJ software. The background of the assay (0.25) was determined by analyzing cells co-
expressing cytosolic RFP and HA tagged NS2; the maximum of colocalization (0.85) was established by using double staining of E2 with two different
antibodies.
doi:10.1371/journal.ppat.1001233.g008
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with its cytosolic localization However, it should be stressed that
helices observed in TMS2 and TMS3 are not classical membrane
anchoring TM helices, since they contain polar and charged
residues. In addition, the TMS2 helix exhibits an amphipathic
character suggesting that it could associate with the membrane
interface, at least transiently. Based on physicochemical consider-
ations, a transmembrane orientation of this helix is expected to be
achieved only upon interaction with another complementary
transmembrane segment neutralizing the polar and charged
residues located in the hydrophobic core of the membrane. In
this context, it is possible that the transmembrane association of
TMS2 and TMS3 occurs in the translocon during NS2
biosynthesis. Alternatively, these TMS might be first released into
the cytosol where they could interact at the membrane interface
and then associate with the membrane to adopt their final
transmembrane topology. Interestingly, the length of the connect-
ing loop between TMS2 and TMS3 and the absence of an
interaction between these TMS suggest that TMS3 might be an
independent entity possibly interacting with distant partners. The
fact that chimeric genomes with high assembly competence can be
obtained when using a cross-over site right after TMS1 of NS2
indicates that TMS1 is functionally separated from the remainder
of the NS2 MBD [14]. Overall, the MBD of NS2 appears to be
composed of a series of structural elements with own functional
properties, but with the capacity to acquire new functions upon
intra- and intermolecular interactions. This structural plasticity is
likely essential to ensure the multiple interactions mediated by the
NS2 MBD.
Genetic analysis of NS2 MBD
Almost all helix-swap mutations reduced assembly competence
arguing for genotype specific incompatibilities between individual
TMS of either NS2 or other viral proteins, such as p7 and E2. The
only exception was mutant CT3.h1 affecting helix1 of TMS3 that
acts most likely as an adaptable linker between TMS2 and TMS3.
This helix is the least conserved sequence of the NS2 MBD
suggesting that it mediates interactions with the membrane in a
genotype-independent manner.
Selection of assembly-impaired NS2 mutants for titer enhancing
mutations compensating the assembly defect to the most part lead
to pseudoreversions within NS2. This was the case for all helix-
swap mutants and several single aa exchanges. Six out of 9
pseudoreversions within NS2 were found in the loop region
Figure 9. Impact of NS2 mutations and the corresponding pseudoreversions on colocalization with structural and nonstructural
proteins and accumulation around LDs. (A) Huh7-Lunet cells were transfected with helix-swap mutation CT1.h or its corresponding
pseudorevertant (CT1.h-p7) and NS2 colocalization with E2, NS3 and NS5A as well as their accumulation around LDs was determined by
immunofluorescence. Cells were analyzed 72 h post transfection as described in Figure 8. The small inserts in the bottom of each panel represent 3D
reconstructed enlargements of each corresponding image created with the Volocity 5.3 software. (B) Colocalization of NS2 with E2 or NS3 or NS5A
was quantified by determining Pearson’s correlation coefficients providing a measure for the relative degree of co-localization of proteins. For each
sample 50 cells were quantified by using the ImageJ software. For further details see legend to Figure 8.
doi:10.1371/journal.ppat.1001233.g009
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connecting TMS1 and 2. This loop resides on the cytosolic side of
the ER membrane and by interaction with membrane phospho-
lipids it may stabilize membrane association of NS2 or is involved
in intra- or intermolecular protein-protein interactions. Overall,
these pseudoreversions most likely restore structural alterations
induced by the primary mutation.
Based on our model of the NS2 MBD (Figure 1D), at least some
of these mutations could be explained. One example is the Y39A
pseudoreversion compensating the assembly defect caused by the
G25R mutation suggesting that aa residues 25 and 39, which are
located on TMS1 and TMS2, respectively, might be in contact
(Figure 10). We assume that the ‘‘hole’’ created in TMS2 by the
Y39A substitution is compensated by a bulky aa in the interacting
TMS1 counterpart, thus ‘filling up’ the hole in the mutated
TMS2. This interaction likely occurs at or close to the membrane
interface, where the charge of Arg is well tolerated. Importantly,
this assumption is corroborated by the G25R pseudoreversion that
was selected with helix-swap mutant JFH1-CT2.h, which has a
histidine residue at position 25. We therefore conclude that the
beginning of the loop between TMS1 and TMS2 likely interacts
with the helix in TMS2. Another example are the pseudorever-
sions K172R and T21A in NS2 that were selected with helix-swap
mutants JFH1-CT3.h2 and JFH1-CT3.h3, respectively, suggesting
interactions between TMS1 and TMS3 (Figure 10). While this can
be easily explained for position 21, the aa at position 172 is more
remote from the membrane surface. Nevertheless, this residue is at
the junction between the two subdomains of the NS2 protease
domain and thus still suitable to contact TMS3.
We tried to integrate all these informations into our NMR-
based structure model of NS2 MBD, but these attempts were
confounded by the fact that NS2 is a dimer, which most likely
forms higher-order oligomeric complexes. Therefore, we do not
know whether a given mutation restores intra- or intermolecular
interactions. Nevertheless, the tight correlation between structural
integrity of NS2 and its role in assembly is underlined by the fact
that titer-enhaning mutations within NS2 have also been found by
us and others when using JFH1 wild type or various virus chimeras
with low assembly competence [10,44–49].
Apart from pseudoreversions within NS2, we also identified two
in p7. Importantly, in case of the helix-swap mutant affecting
TMS1, the pseudoreversion in p7 (E3D) enhanced virus
production almost back to wild type level. This result argues for
an interaction between TMS1 of NS2 and p7 (Figure 10).
Unfortunately, this assumption could not be tested directly,
because this mutation destroyed the epitope recognized by the
p7-specific antibody. However, we have earlier described that for
most virus chimeras the best junction for fusion of the genome
segments resides after TMS1 of NS2, whereas an intergenotypic
fusion right after p7 was severely impaired in assembly [14]. Thus,
genotypic compatibility between TMS1 of NS2 and the structural
proteins as well as p7 appears to be required for efficient assembly.
A direct interaction between NS2 and envelope glycoproteins
might be suggested by the pseudoreversions V341A residing in the
N-terminus of the TMS of E2 and mutation I181S in E1
(Figure 10). We note that V341 in E2 and the primary NS2
mutation F77 responsible for the assembly defect are both most
Figure 10. Summary of interactions within NS2 and with HCV proteins as deduced from the genetic analysis. The structural models of
NS2 (this study), p7 [16], the transmembrane domain of E1 (TM-E1;[68]) and E2 (TM-E2; theoretical model) are represented as ribbon. The
phospholipid bilayer is indicated tentatively and schematically. Only the side chains of aa encoded by pseudoreversions are shown with spheres
correspondı´ng to van der Waals radia. Residues likely involved in intra- or inter-molecular interactions are indicated with the same color and
connected with double arrows. Interactions within and outside of NS2 are represented by small and large double arrows, respectively. The backbone
of aa residues with low similarity identified in helix-swap mutants and potentially involved in inter-helix interactions are colored violet as in Figure 1D.
The large gray arrow indicates the region of NS2 likely involved in interaction with NS3. Residues colored in pink-gray (position 45) and light green
(position 73) correspond to pseudoreversions at the very same site as the original NS2 mutation. Numbering of altered residues in TM-E1 and TM-E2
correspond to JFH1 and numbers in parenthesis correspond to the H77 reference polyprotein. The molecular models of TM-E1 and TM-E2 were
constructed by using the Swiss Model server facilities (http://www.expasy.ch/swissmod/). The figure was generated on the basis of the structure
coordinates by using the Visual Molecular Dynamics program and rendered with POV-Ray.
doi:10.1371/journal.ppat.1001233.g010
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likely located in the membrane hydrophobic core, close to the ER
membrane interface (Figure 1D for NS2 and Figure 1 in [50] for
E2). Moreover, I181S in E1 selected as pseudoreversion with the
helix-swap mutant CT3.h2 resides in the center of the TMS of E1
and thus could also directly form a stable in-membrane interaction
with NS2 (Figure 10).
W35F and W36L independently adapted via the Q221L
pseudoreversion in NS3 that has also been found in two earlier
reports [25,51]. This reversion is highly potent and restores viral
infectivity up to ,38,000-fold. Interestingly, this NS3 mutation
also rescues assembly in trans showing that the replication and
assembly function of NS3 can be separated genetically. While the
mechanism by which Q221L enhances assembly is not known, we
note that this residue resides on the helicase NTPase subdomain
surface in a basic patch and is well accessible. This positively
charged surface area might interact with the membrane surface by
electrostatic interactions. In this way the aa residue at position 221
could contact the NS2 MBD at the membrane interface, at least
transiently (Figure 10). According to this hypothesis, the
replacement of the polar residue (Q) by a large hydrophobic aa
(Leu) might reinforce membrane binding.
Protein interaction and subcellular localization of NS2
Co-immunoprecipitation studies revealed stable interactions of
NS2 with NS3, p7 and E2 whereas interaction with NS5A was
rather weak. Importantly, none of the tested conditions revealed
NS2 interaction with core. These results were well supported by
immunofluorescence studies demonstrating a profound and rapid
colocalization of NS2 with E2 and NS3 at the ER or an ER-
derived membrane compartment prior to accumulation around
LDs. Several lines of evidence suggest that NS2 recruits E2 –and
thus most likely also E1 that forms a very stable E1/E2
heterodimer [52]– and eventually also p7 to assembly sites in
close proximity of LDs. First, we detected a profound colocaliza-
tion of NS2 and E2 for each time point after infection or
transfection; second, in NS2 assembly-defective viruses E2
localized primarily to the ER; third, upon insertion of the
corresponding pseudoreversion E2 and NS2 colocalized again to
LDs. The NS2-independent LD localization of NS5A and its weak
interaction with NS2 is in agreement with previous data showing
that NS5A expressed on its own is targeted to LDs, for which the
N-terminal amphipathic helix appears to be most critical [33].
No significant colocalization of NS2 and core at LDs was
detected. However, a small fraction of core protein presumably
residing at the ER colocalized with NS2 both at the early and the
late time points after transfection. Although LDs have been
described as sites of HCV assembly [31] the weak NS2 – core
colocalization is not in contradiction to this observation. In fact, it
is speculated that the early steps of HCV assembly (nucleocapsid
formation) might take place at LDs whereas the envelopement is
thought to occur at the ER or an ER-derived compartment. Since
NS2 probably acts at a late step of assembly [27] and might be
involved in envelopment of the nucleocapsid, the colocalization of
core and NS2 at the ER in close proximity of LDs rather than
directly on LDs would support such a model. Moreover, given the
complex membrane topology of NS2 this protein most likely can
not move onto the surface of LDs that is formed by a membrane
monolayer.
A hypothetical model how NS2 contributes to HCV
assembly
The results described in this study together with earlier reports
[25,27] invite speculation how NS2 might contribute to assembly.
It is assumed that the early steps (nucleocapsid formation) occur in
close proximity of LDs that may serve as assembly platforms [31].
By interaction between core and (RNA-containing) NS5A, capsid
formation might be triggered [32]. How the envelope is acquired is
not known, but we assume that NS2 plays a central role in this
step. Since the TMS of E1 and E2 lack a cytosolic domain that
could interact with the core protein, an adaptor protein such as
NS2 that in turn efficiently binds p7 and E2 (and the latter forming
heterodimers with E1), might be required to ‘deliver’ the envelope
proteins to assembly sites in close proximity of LDs. This process
could be facilitated by a particular membrane lipid environment
supporting recruitment of the NS2 complex as well as the (lipid-
binding) nucleocapsid. Alternatively, one or several host cell
factors such as CIDE-B, described as an NS2 interactant [53] and
required for lipid homeostasis [54], might be recruited by NS2 and
aid in assembly. Moreover, NS2 efficiently binds to NS3 arguing
that NS2 can form an additional complex with the replicase. How
such a complex would contribute to assembly is unclear, but it may
‘tether’ the replicase to the assembly sites thus facilitating core –
NS5A interaction. Alternatively, NS2 may form just one higher-
order protein complex including in addition to E1/E2 and p7
NS3. This is probably facilitated by the N-terminal MBD that
might form ‘clusters’ within the membrane. Finally, it is possible
that the strong NS2 - NS3 interaction affects cleavage at the NS2-3
site, in this case contributing to assembly in a rather indirect
manner.
In conclusion, our results point to a central role of NS2 in HCV
assembly by formation of (a) multiprotein complex(es) with
structural and eventually also nonstructural proteins and recruiting
them to assembly sites in close proximity of LDs. In this respect,
NS2 acts as a central organizer of HCV virion formation.
Materials and Methods
Sequence analyses and predictions
Sequence analyses were performed by using Network Protein
Sequence Analysis (NPSA) (http://npsa-pbil.ibcp.fr [55]) and
European HCV Database (http://euhcvdb.ibcp.fr [56]). Multiple-
sequence alignments were performed with CLUSTAL W [57], by
using the default options. Protein secondary structures were
deduced from a large set of prediction methods available at the
NPSA website, including HNNC, SIMPA96, MLRC, SOPM,
PHD, and Predator (http://npsa-pbil.ibcp.fr/NPSA and references
therein). Octanol hydrophobicity plots were generated with MPEx
(http://blanco.biomol.uci.edu/mpex/) by using the scale developed
by Wimley and White [58].
Cell culture
Monolayers of the highly permissive cell lines Huh7-Lunet [59]
and Huh7.5 [60] were grown in Dulbecco’s modified minimal
essential medium (DMEM; Life Technologies, Karlsruhe, Ger-
many) supplemented with 2 mM L-glutamine, nonessential amino
acids, 100 U/ml of penicillin, 100 mg/ml of streptomycin, and
10% fetal calf serum. Owing to highest permissiveness for JFH-1,
Huh7.5 cells were used for virus production and infection assays
whereas Huh7-Lunet cells and derivatives thereof were used for
immunofluorescence analyses because of their superior morphol-
ogy as compared to Huh7.5 cells.
Plasmids and DNA cloning
NS2-GFP fusion constructs were derived from pFK1-9605Con1
([7]; HCV Con1 strain). First, a BamHI restriction site was
eliminated by introducing a silent mutation replacing the cytidine
at nucleotide position 2920 by an adenosine. Sequences encoding
NS2 fragments from codon 1–27, or 27–59, or 60–99, or 1–99 or
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the complete NS2 coding region were fused to EcoRI and BamHI
recognition sequences by PCR and amplified fragments were
inserted via these two restriction sites into pCMV-KEB-GFP [61],
yielding constructs pCMVNS21-27-GFP, pCMVNS227-59-GFP,
pCMVNS260-99-GFP, pCMVNS21-99-GFP and pCMVNS2-
GFP.
Unless otherwise stated all mutations were introduced into
JFH1mut4-6 [10] corresponding to the JFH1 genome [9], but
containing three virus titer enhancing mutations that do not affect
RNA replication (V2153A, V2440L and V2941M). All nucleotide
and aa numbers refer to the JFH1 genome (GenBank accession
no. AB047639). Single aa substitutions and helix-swap mutations
were introduced by PCR-based site-directed mutagenesis or
overlap-PCR, respectively, using standard procedures. In case of
the helix-swap mutations the following nucleotide sequences of
JFH1 were replaced by the corresponding sequences of Con1:
nucleotides 2811 - 2839 in case of pFK-JFH1-CT1.h; nucleotides
2879 - 2911 for pFK-JFH1-CT2.h; nucleotides 2967 - 2986 for
pFK-JFH1-CT3.h1; nucleotides 3002 - 3025 in case of pFK-
JFH1-CT3.h2; nucleotides 3047 - 3070 with pFK-JFH1-CT3.h3.
To generate the JFH1 genome encoding a tagged NS2 protein a
sequence encoding the peptide YDAPVSGDYKDDDDKGSG
(corresponding to the first 5 aa of NS2, a 2 aa flexible linker (SG)
containig a BspEI site, a Flag tag and a flexible GSG linker) was
inserted by overlap PCR between nucleotide 2779 and 2780 of the
JFH1 genome. A silent G to A mutation at position 2794 was
introduced to create a BsrGI restriction site whereas the natural
BsrGI site at position 7786 was destroyed by a silent A to T
mutation. In addition, a silent A to C nucleotide substitution at
position 1741 was introduced to create a dam methylation site
affecting the BspEI cleavage site at this position. To generate
genomes with double tagged NS2, oligonucleotides encoding the
Flag-, or hexahistidine- or HA-tag fused to the GSG linker were
inserted in-frame into the BspEI site.
In vitro transcription and electroporation of HCV RNAs
The experimental procedures used to generate in vitro
transcripts from cloned HCV sequences and transfection of
Huh-7 cells by electroporation have been described in detail
recently [6]. For trans-complementation assays a mixture of 7.5 mg
NS2 mutant and 5 mg helper replicon RNA was used. After
electroporation, cells were immediately transferred to complete
DMEM and seeded as required for the assay.
Immunohistochemical staining and virus titration
Virus titers were determined as described elsewhere with slight
modifications [13]. In brief, Huh7.5 cells were seeded into 96-well
plates and fixed 3 - 4 days after infection. For immunohistochem-
istry we used an antibody specific for the JFH1 NS3 helicase (2E3,
generated in cooperation with H. Tang, Florida State University,
USA) at a dilution of 1:100 or the 9E10 monoclonal antibody
specific against NS5A protein in dilution 1:2,000 (NS5A-9E10;
kindly provided by C.M. Rice, New York, USA). Bound antibody
was detected with a peroxidase-conjugated secondary antibody
specific to murine IgG (Sigma-Aldrich) diluted 1:200 in PBS. Virus
titers (50% tissue culture infective dose per ml; [TCID50/ml]) were
calculated as described recently [62].
Selection for pseudorevertants
Huh7.5 cells were electroporated with 10 mg in vitro transcript
and culture supernatant harvested 72 h later was concentrated by
ultrafiltration using an Amicon Ultra Centrifugal Filter Column
(Milipore). Naı¨ve Huh7.5 cells were inoculated with this
concentrate and continuously passaged up to 6 times. Thereafter,
culture supernatants were passaged 4 times on naı¨ve Huh7.5 cells
and virus titers were determined by TCID50 or immunofluores-
cence assay. Details of the adaptation method have been described
elsewhere [63].
Preparation of total RNA, amplification of replicon RNA
by RT-PCR and cloning of amplified DNA fragments
HCV RNA present in Huh7.5 cells was amplified and cloned as
described previously [10,63]. In brief, total RNA was isolated from
a confluent 10 cm-diameter dish of Huh7.5 cells infected with the
adapted virus population by using the Nucleo Spin RNAII Kit
(Macherey-Nagel, Du¨ren, Germany) as recommended by the
manufacturer. One mg total RNA and 50 pmol of primer A9482
(59-GGA ACA GTT AGC TAT GGA GTG TAC C-39) were
applied for cDNA synthesis by using the Expand-RT system
(Roche, Mannheim, Germany) as recommended by the manufac-
turer. Two to four microliters of the reaction mixture were used to
amplify the 59 half of the HCV genome with the Expand Long
Template PCR kit (Roche) according to the instructions of the
manufacturer with primers S59-EcoRI (59-TGT CTT CAC GCA
GAA AGC GCC TAG-39) and A4614 (59-CTG AGC TGG TAT
TAT GGA GAC GTC C-39). PCR products were directly
sequenced (mutants G10S, E45R, P73I and F77A) or inserted into
pFK-I389Luc-EI/NS3-39/JFH1-dg after restriction with EcoRI
and SpeI. Sequence analysis of two independent plasmid clones
was performed with an appropriate set of primers.
Antisera
The following antisera were used in this study: rabbit polyclonal
antibody specific for NS2 (NS2-1519; [6]); rabbit polyclonal
antibody specific for the core protein (C-830; [64]); rabbit
polyclonal antibody specific for NS3 of JFH1 (NS3-4949; [30]);
mouse monoclonal antibody specific for JFH1 NS3 (NS3-2E3;
generated in co-operation with H. Tang, Florida State University,
USA); rabbit polyclonal antibody specific for JFH1 NS5A (NS5A-
52; [6]); mouse monoclonal antibody specific for NS5A (NS5A-
9E10, kindly provided by C.M. Rice, New York, USA); rabbit
polyclonal anti p7-2716 and anti p7-2717 (kindly provided by M.
Harris and S. Griffin, Leeds, UK); rabbit polyclonal antibody
specific for J6 E2 [6]; mouse monoclonal antibody specific for E2
protein (AP33, kindly provided by Arvin Patel, Glasgow, U.K.);
mouse monoclonal anti-Flag antibody, mouse monoclonal anti-
HA antibody and mouse monoclonal anti-b-actin, all from Sigma-
Aldrich (Munich, Germany). Monoclonal antibody (mAb) 1D3
against protein disulfide isomerase (PDI) was purchased from
StressGen (Victoria, BC, Canada).
SDS PAGE and Western blot
Western blot analysis was performed as described previously
[6]. Samples harvested 48 h after transfection were heated for
20 min at 95uC in sample buffer (125 mM Tris/HCl, 2% (w/v)
SDS, 5% (v/v) 2-mercaptoethanol, 10% (v/v) glycerol, 0.001%
(w/v) bromophenol blue, pH 6.8) and separated by SDS
polyacrylamide gel electrophoresis. Proteins were electro-trans-
ferred to a polyvinylidene fluoride (PVDF) membrane (PerkinEl-
mer Life Sciences) for 1 h. Membrane was blocked overnight in
PBS supplemented with 0.5% Tween (PBS-T) and 5% dried milk
(PBS-M) at 4uC prior to 1 h incubation with primary antibody
diluted in 2% milk in PBS-T. Membrane was washed 3 times with
PBS-T and incubated for 1 h with horseradish-peroxidase
conjugated secondary antibody. Bound antibodies were detected
after 3 times washing with the ECL Plus Western Blotting
Detection System (GE Healthcare Europe, Freiburg, Germany).
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Co-immunoprecipitation
Huh7.5 cells were mock treated or transfected with HCV RNA,
and samples were harvested 72 h later by scraping into IP buffer
(0.5% n-dodecyl-b-D-maltoside, 100 mM NaCl, 20 mM Tris
pH 7,5). After 60 min incubation on ice, cell debris was removed
by 15 min centrifugation at 20,000xg. Samples were incubated
with HA-specific antibody beads (Sigma Aldrich) over night at
4uC. After three times washing with IP buffer, samples were eluted
into sample buffer and separated by electrophoresis into a 11%
Tris-Tricine gel as described elsewhere [65]. Proteins were
transferred onto PVDF membrane and HCV proteins were
detected by Western blot as described above.
Immunofluorescence and confocal laser scanning
microscopy
U-2 OS human osteosarcoma cells grown on glass coverslips were
transfected with GFP fusion constructs, fixed 24 to 48 h post
transfection with 2% paraformaldehyde, and mounted in SlowFade
(Molecular Probes, Eugene, OR). Immunofluorescence staining was
performed as described previously [66]. Bound primary antibody was
revealed with Alexa-488-conjugated goat anti-mouse antibody
(Molecular Probes). Mounted coverslips were examined using a
Leica SP5 AOBS confocal laser scanning microscope. Immunoflu-
orescence detection of HCV proteins in Huh7-Lunet cells was
conducted in the analogous way with some modifications. Cells were
transfected with HCV RNA and fixed 24, 36, 48 and 72 h post-
transfection with 4% paraformaldehyde. Bound primary antibodies
were detected with a Alexa-488-conjugated goat anti-rabbit antibody
or a Alexa-568-conjugated goat anti-mouse antibody (Molecular
Probes). LDs were stained with HCS LipidTOXTM Deep Red
neutral lipid stain (Molecular Probes). Coverslips were mounted in
Fluoromount-G mounting medium (Electron Microscopy Sciences,
Ft. Washington, USA) and examined with a Perkin Elmer spinning
disk confocal ERS 6Line microscope. Images were deconvolved with
the Huygens Essential 3.5 software using a theoretical point spread
function. 3D reconstructed images were created using the Volocity
5.3. software package.
Peptide synthesis and purification
The NS2[27-59] and NS2[60-99] peptides representing aa
segments 27–59 and 60–99 of NS2 of the Con1 strain (AC number
AJ238799) were synthetized by Clonestar Biotech and purified by
RP-HPLC (purity .98%).
Structure determination by CD and NMR
CD, NMR spectroscopy, NMR-derived constraints and struc-
ture calculation, and molecular modeling and structure represen-
tation were performed by standard approaches as described in
materials and methods S1.
Accession codes
The atomic coordinates for the NMR structures of peptides
NS2[27-59] and NS2[60-99] and the NMR restraints in 50% TFE
are available in the Research Collaboratory for Structural Bioinfor-
matics (RCSB) Protein Data Bank under accession number 2KWT
and 2KWZ respectively. The chemical shifts of all NS2[27-59] and
NS2[60-99] residues have been deposited in the BioMagResBank
(BMRB) under the accession number 16886 and 16892, respectively.
Supporting Information
Figure S1 Sequence analyses and secondary structures of NS2
transmembrane segments as determined by CD spectroscopy and
NMR. (A) NS2 secondary structure prediction of the isolates H77,
Con1, and JFH1 (genotypes 1a, 1b and 2a, respectively). Numbers
in the top refer to residues of the HCV polyprotein and NS2,
respectively. Secondary structure predictions are indicated as
helical (h, blue), extended (e, red), turn (t, green), or undetermined
(coil [c], yellow). Predictions were made as described in materials
and methods. Sec. Cons., secondary structure consensus. (B)
Octanol hydrophobicity plot generated with MPEx (http://
blanco.biomol.uci.edu/mpex/) using the Wimley and White scale
of octanol hydrophobicity [58]. The plot shows the mean values
using a window of 19 residues. The consensus segments exhibiting
a propensity to partition into the hydrophobic core of the lipid
bilayer are indicated by the dash bars. (C) Far-UV circular
dichroism (CD) analyses of synthetic peptides NS2[27-59] and
NS2[60-99] in various membrane mimetic environments. CD
spectra were recorded in either 50% 2,2,2-trifluoroethanol (TFE)
or 1% L-a-lysophosphatidyl choline (LPC), or the following
detergents: 100 mM sodium dodecyl sulfate (SDS), 100 mM n-
dodecyl-b-D-maltoside (DM), or 100 mM dodecyl phosphocholine
(DPC). (D, E) NMR analysis of the peptides in 50% TFE. A
summary of sequential (i, i+1) and medium-range (i, i+2 to i, i+4)
NOEs is shown in panel D. Sequential NOEs allowing the
assignment of proline residues are indicated in red. Asterisks
indicate that the presence of a NOE cross peak was not confirmed,
because of overlapping resonances. Intensities of NOEs are
indicated by the height of the bars. (E) NMR-derived 1Ha
chemical shift differences (in parts per million) were calculated by
subtraction of the experimental values from the reported random
coil conformation values in TFE, respectively. [69]. The dashed
lines indicate the standard threshold value of DHa for an a-helix
(20.1 ppm).
Found at: doi:10.1371/journal.ppat.1001233.s001 (1.71 MB TIF)
Figure S2 NS3 is able to rescue assembly-deficient NS2 mutants
in trans. (A) To determine wether the NS3 mutation Q221L is able
to rescue assembly deficient genomes in trans the substitution was
inserted into a JFH1 replicon RNA. This construct had a deletion
in NS5A (NS5AD3) that prevents detection with the monoclonal
antibody 9E10 thus allowing the selective detection of the
assembly mutant that has an unaltered NS5A [6]. Replicon
helper RNA (NS3-39replicon) was co-transfected with assembly
deficient NS2 mutants (JFH1mut4-6 or derivatives thereof
carrying mutations affecting W35 or W36) at a ratio of 1: 1.5
into Huh7.5 cells. (B) Supernatants were harvested 48 h after
transfection and released infectivity was determined by TCID50
assay using the NS5A-specific antibody 9E10. A representative
result of two independent experiments with standard deviations is
shown. Background of the assays was determined by using JFH1-
DE1E2 (black line and arrow head). (C) Cell lysates of cells
transfected with HCV RNAs specified in the bottom were
harvested 48 h after transfection and proteins were analyzed by
Western blot. Detected proteins are specified in the left of each
panel. Note that NS5AD3 is expressed only from the subgenomic
helper RNA whereas full length NS5A is expressed only from the
complete JFH1mut4-6 genome or the NS2 mutants derived
thereof. Actin was detected on the same blot and served as loading
control. The replicon helper RNA did not affect infectivity titer of
wild type virus. However, upon co-transfection of the replicon
containing the Q221L mutation, the assembly defect of mutants
W35F and W36 was rescued ,20 or 50-fold, respectively in
comparison to titers attained in the absence of this helper RNA.
Thus, rescue by NS3-Q221L in trans is possible although
infectivity titers are ,100- or 1000-fold lower as compared to
rescue in cis.
Found at: doi:10.1371/journal.ppat.1001233.s002 (1.18 MB TIF)
Role of NS2 in HCV Assembly
PLoS Pathogens | www.plospathogens.org 20 December 2010 | Volume 6 | Issue 12 | e1001233
Figure S3 Intracellular infectivity correlates with infectivity
release in viruses carring pseudoreversions within and outside of
NS2. JFH1 mutants carrying single aa substitutions (A) or helix
swap mutations (B) with severe impact on virion production were
used for insertion of pseudoreversions specified in Table 1. The
parental mutant and the corresponding double mutant (containing
the pseudoreversion) were transfected into Huh7.5 cells and intra-
as well as extracellular infectivity was determined 48 h after
transfection by TCID50 assay. A representative result of two
independent experiments with standard deviations is shown.
Background of the assays was determined by using JFH1-DE1E2
(black line and arrow head). For nomenclature of the mutants see
Table 1.
Found at: doi:10.1371/journal.ppat.1001233.s003 (0.30 MB TIF)
Figure S4 No gross effect of pseudoreversions within and outside
of NS2 on RNA replication or stability of HCV proteins. JFH1
mutants carrying mutations specified in the bottom of each panel
with or without additional pseudoreversions were transfected into
Huh7.5 cells. After 48 h, NS5A, NS3, core and actin (internal
loading control) were analyzed by Western blot.
Found at: doi:10.1371/journal.ppat.1001233.s004 (2.53 MB TIF)
Figure S5 Changes of NS2 subcellular localization in Huh7 cells
after infection. Huh7-LunetCD81H cells [62] were infected with
JFHmut4-6HAF-NS2 and 36, 48 and 72 h later, NS2 and LDs
were detected by using an HA-specific antibody or BODIPY
staining, respectively. For each time point, 180 cells were
analyzed. Note that the changes of NS2 subcellular localization
in these infected cells very well compare to data obtained by RNA
transfection (Figure 8).
Found at: doi:10.1371/journal.ppat.1001233.s005 (0.08 MB TIF)
Figure S6 Colocalization of NS2 and core in Huh7 cells. Huh7-
LunetCD81H cells [62] were transfected with JFH1mut4-6HAF-
NS2 and 36 h (A) or 72 h later (B) NS2 colocalization with core
was determined by immunofluorescence analysis. NS2 was
detected with an HA-specific antibody (red), core with a mono-
specific antiserum (green) and LDs were labeled with BODIPY
(blue). Note the very limited colocalization of core and NS2
around LDs (best visible in the magnifications shown in the bottom
right of panel A and B). However, colocalization was detected in a
more reticular compartment next to LDs.
Found at: doi:10.1371/journal.ppat.1001233.s006 (4.21 MB TIF)
Materials and Methods S1
Found at: doi:10.1371/journal.ppat.1001233.s007 (0.06 MB
DOC)
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